DELVE BLOG
Delve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient’s Lifestyle
For A Monkey Pox Treatment: US Government Shows Initiative
The United States government is no stranger to being proactive when it comes to outbreaks of deadly diseases. In the face of a potential monkeypox epidemic, the US government has taken swift and decisive action in the form of clinical trials for potential treatment. This article will explore what monkeypox is, the symptoms of this virus, and how the US government is racing against time to find a cure. What is monkeypox? Monkeypox is a rare viral disease that is similar to smallpox, but much less severe. It is a zoonotic disease, which means that it is spread
Delve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient’s Lifestyle—Not the Other Way Around
A significant number of companies announced delays and cancellations to planned and on-going clinical trials because of COVID-19 lockdowns and social distancing measures. There was a peak of 1,265 trials paused or indefinitely delayed in June 2020—impacting nearly 1,000 companies. Disruptions included delayed initiation or complete withdrawal of planned trials, as well as suspended enrollment or cancellation of on-going trials. The number of disrupted trials has been falling slowly since June 2020, with most current disruptions due to other factors, such as slow enrollment. A Sharp Increase in Virtual Clinical Trial Providers Several start-ups have emerged in the virtual trials
Remote Patient Monitoring in Clinical Trials
In 1958, AT&T came out with the Bell 101 modem—the first commercial modem to transmit data via what would later be known as “the internet.” Shortly after, in 1959 Wilson Greatbatch patented the first internal pacemaker, which was first implanted inside a human in 1960. However, it wasn’t until 2001 when these advancements directly had a hand in changing the clinical research field. Biotronic had an approved remote monitoring system, where a user had to dial a phone number and let the phone listen to an ICD device and record the information being transmitted. Those technological gains lead to the
Opinion: We Have Been Gifted a New Outlook on Increasing Patient Diversity, Compliance, and Retention in Clinical Trials
ACRP Clinical Researcher—June 21, 2022 Our own co-founder and CEO of Delve Health, Wessam Sonbol was published in the ACRP Clinical Researcher magazine. The article’s text is below, but you can also check it out here. Clinical Researcher—June 2022 (Volume 36, Issue 3) RECRUITMENT & RETENTION Wessam Sonbol, CSM, CSPO, ICP-ACC The COVID-19 pandemic has changed the entire world over the last two years. Life, as we knew it, stopped. Terms like “social distancing” and “masking up” will now be a part of our lexicon forever. In our industry, 70% of clinical trials were put on hold with everyone
Conversations On the Ground—Traditional CROs vs. Virtual CROs
Delve Health’s upper management is currently attending the Drug Information Association’s (DIA) 2022 Global Annual Meeting in Chicago, Illinois. While we are taking all the necessary precautions to avoid the spread of COVID-19, we are very happy to be on the ground and in-person for this meeting, after a two-year absence. We hadn’t been on-site long and we’ve already had some very interesting and informative conversations with fellow attendees, one of which was regarding the “pros” of virtual research organizations (CROs), such as Delve Health, and the “cons” of traditional CROs. Traditional CROs vs. Virtual CROs The clinical research
